GWW
67
3
GILD
62
2
BDX
41
3
DHI
48
4
MPC
31
5
BWA
44
3
OI
34
6
BMY
43
2
PYPL
41
2
FTI
66
2
TJX
43
3
ETN
69
2
GD
44
2
MU
39
5
R
67
4
CHRW
53
3
MS
69
3
GS
63
11
PPL
54
5
ICE
57
2
GWW
67
3
GILD
62
2
BDX
41
3
DHI
48
4
MPC
31
5
BWA
44
3
OI
34
6
BMY
43
2
PYPL
41
2
FTI
66
2
TJX
43
3
ETN
69
2
GD
44
2
MU
39
5
R
67
4
CHRW
53
3
MS
69
3
GS
63
11
PPL
54
5
ICE
57
2
Financhill
Back

Xeris Biopharma Holdings Quote, Financials, Valuation and Earnings

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!
Buy
88

XERS
Xeris Biopharma Holdings

Last Price:
3.34
Seasonality Move:
0.46%

7 Day Trial

ALL ACCESS PASS

$ 7

U.S. Government Report Alert Tuesday

Discover the Secret Loophole

Xeris Biopharma Holdings Price Quote

$3.34

Xeris Biopharma Holdings Key Stats

Buy
88
Xeris Biopharma Holdings (XERS) is a Buy
Day range:
$3.25 - $3.39
52-week range:
$1.46 - $3.39
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.54
P/B ratio:
0%
Volume:
2.2M
Avg. volume:
1.2M
1-year change:
80.54%
Market cap:
$485.7M
Revenue:
$163.9M
EPS:
$-0.42

How Much Does Xeris Biopharma Holdings Make?

Is Xeris Biopharma Holdings Growing As A Company?

Xeris Biopharma Holdings Stock Price Performance

What Is Xeris Biopharma Holdings 52-Week High & Low?

Xeris Biopharma Holdings Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Xeris Biopharma Holdings?

Is Xeris Biopharma Holdings Cash Flow Positive?

  • What Is XERS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$37.8M
  • What Is Xeris Biopharma Holdings’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $34.5M
  • What Is Xeris Biopharma Holdings’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $14.5M

Xeris Biopharma Holdings Return On Invested Capital

  • Is Management Doing A Good Job?
    XERS return on invested capital is -29.43%
  • What Is Xeris Biopharma Holdings Return On Assets?
    ROA measures how assets are converting to revenues and is -18.08%
  • What Is XERS Return On Equity?
    ROE is a measure of profitability and is 0%

Xeris Biopharma Holdings Earnings Date & Stock Price

Xeris Biopharma Holdings Competitors

Xeris Biopharma Holdings Dividend Yield

Xeris Biopharma Holdings Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -6.38%
Revenue: 26.46% 4.92%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 4.67
Upside from Last Price: 39.72%

Major Shareholders

  • How many XERS shares are owned by institutional investors?
    85.4M XERS shares are owned by institutional investors
  • How many XERS shares are owned by insiders?
    13.4M XERS shares are owned by insiders